EuBiologics Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-13,879	-1,099	-27,574	-60,134
Depreciation & Amortization	9,168	7,882	6,564	5,949
Loss (Gain) From Sale of Assets	-1,666	-193.28	0.88	5.24
Asset Writedown & Restructuring Costs	21,906	845.09	708.04	-
Loss (Gain) From Sale of Investments	200.32	-2,142	-253.29	180.59
Loss (Gain) on Equity Investments	512.58	321.04	124.61	0.15
Stock-Based Compensation	777.07	4,032	1,992	346.27
Provision & Write-off of Bad Debts	-6.28	44.04	-106.53	260.57
Other Operating Activities	2,192	3,531	19,866	52,844
Change in Accounts Receivable	-2,747	-700.88	-1,144	-1,775
Change in Inventory	3,754	-6,679	-5,153	-1,643
Change in Accounts Payable	-220.46	548.03	-405.95	-96.77
Change in Other Net Operating Assets	6,460	50.79	-2,221	5,723
Operating Cash Flow	26,452	6,440	-7,602	1,659
Operating Cash Flow Growth	310.73%	-	-	-
Capital Expenditures	-6,936	-9,066	-6,595	-8,030
Sale of Property, Plant & Equipment	89	-	0.29	5
Cash Acquisitions	-	-	-729.7	-
Sale (Purchase) of Intangibles	-36,721	-15,860	-2,565	-1,909
Investment in Securities	9.39	22,844	-28,296	-4,499
Other Investing Activities	15,128	-136.27	-31.84	-76.91
Investing Cash Flow	-28,110	-2,132	-38,244	-15,245
Short-Term Debt Issued	2,663	6,000	-	5,402
Long-Term Debt Issued	-	-	-	4,000
Total Debt Issued	2,663	6,000	-	9,402
Short-Term Debt Repaid	-2,507	-	-2,300	-901.82
Long-Term Debt Repaid	-1,431	-7,176	-769.91	-658.66
Total Debt Repaid	-3,938	-7,176	-3,070	-1,560
Net Debt Issued (Repaid)	-1,274	-1,176	-3,070	7,841
Issuance of Common Stock	61.86	1,093	1,326	53,062
Other Financing Activities	1,779	717.31	1,031	104.41
Financing Cash Flow	566.03	634.58	-712.61	61,008
Foreign Exchange Rate Adjustments	-54.9	-432.88	4.52	-1.9
Net Cash Flow	-1,147	4,509	-46,554	47,421
Free Cash Flow	19,515	-2,626	-14,196	-6,371
Free Cash Flow Margin	28.13%	-4.74%	-36.05%	-22.36%
Free Cash Flow Per Share	535.43	-72.15	-400.46	-227.38
Cash Interest Paid	746.56	566.16	554.79	512.78
Cash Income Tax Paid	-37.16	3.25	43.52	-3.41
Levered Free Cash Flow	-30,178	-18,184	-34,456	-
Unlevered Free Cash Flow	-29,873	-18,024	-34,088	-
Change in Working Capital	7,247	-6,781	-8,924	2,208

Updated Mar 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.